Edwards Lifesciences (EW) to Discontinue its Optiwave 980 Cardiac Laser Ablation System, Sees $16 Million Charge in Q4
Tweet Send to a Friend
Edwards Lifesciences Corporation (NYSE: EW) announced the discontinuation of its Optiwave 980 Cardiac Laser Ablation System. In addition, Edwards ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
